Dayatan, Lovely Joy .

HRN: 16-99-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
CEFUROXIME 1.5GM (VIAL)
06/13/2022
06/20/2022
IVT
1.2GM
Q8h
PCAP-B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: